Mersana Therapeutics, Inc. Interest Expense on Debt
Mersana Therapeutics, Inc. reported Interest Expense on Debt of $700.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2022-05-09
- Mersana Therapeutics, Inc. interest expense, debt for the quarter ending 2022-03-31 was $700.00K, a 600.00% increase year-over-year.
- Mersana Therapeutics, Inc. interest expense, debt for the quarter ending 2021-12-31 was $530.00K, a 217.37% increase year-over-year.
- Mersana Therapeutics, Inc. interest expense, debt for the quarter ending 2021-09-30 was $90.00K, a 50.00% increase year-over-year.
- Mersana Therapeutics, Inc. interest expense, debt for the quarter ending 2021-06-30 was $89.00K, a 74.51% increase year-over-year.
- Mersana Therapeutics, Inc. interest expense, debt for fiscal 2021 was $797.00K, a 134.41% increase from fiscal 2020.
- Mersana Therapeutics, Inc. interest expense, debt for fiscal 2020 was $340.00K, a 58.88% increase from fiscal 2019.
- Mersana Therapeutics, Inc. interest expense, debt for fiscal 2019 was $214.00K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 3 month as first filed | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | $700.00K 10-Q · filed 2022-05-09 | $1.23M derived: sum of 2 quarters · filed 2022-05-09 | $1.32M derived: sum of 3 quarters · filed 2022-05-09 | $1.41M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-12-31 | $530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $620.00K derived: sum of 2 quarters · filed 2022-02-28 | $709.00K derived: sum of 3 quarters · filed 2022-02-28 | $797.00K 10-K · filed 2022-02-28 | |
| 2021-09-30 | $90.00K 10-Q · filed 2021-11-09 | $179.00K derived: sum of 2 quarters · filed 2021-11-09 | $267.00K 10-Q · filed 2021-11-09 | $446.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-06-30 | $89.00K 10-Q · filed 2021-08-06 | $177.00K 10-Q · filed 2021-08-06 | $356.00K derived: sum of 3 quarters · filed 2022-05-09 | $416.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-09 | $88.00K 10-Q · filed 2021-05-10 | $267.00K derived: sum of 2 quarters · filed 2022-05-09 | $327.00K derived: sum of 3 quarters · filed 2022-05-09 | $378.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $227.00K derived: sum of 2 quarters · filed 2022-02-28 | $278.00K derived: sum of 3 quarters · filed 2022-02-28 | $340.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | $60.00K 10-Q · filed 2021-11-09 | $111.00K derived: sum of 2 quarters · filed 2021-11-09 | $173.00K 10-Q · filed 2021-11-09 | $312.00K derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $51.00K 10-Q · filed 2021-08-06 | $102.00K 10-Q · filed 2021-08-06 | $252.00K derived: sum of 3 quarters · filed 2021-08-06 | $303.00K derived: sum of 4 quarters · filed 2021-08-06 | |
| 2020-03-31 | $51.00K 10-Q · filed 2021-05-10 | $201.00K derived: sum of 2 quarters · filed 2021-05-10 | $252.00K derived: sum of 3 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $201.00K derived: sum of 2 quarters · filed 2021-02-26 | $214.00K 10-K · filed 2021-02-26 | ||
| 2019-09-30 | $51.00K 10-Q · filed 2020-11-09 | $64.00K 10-Q · filed 2020-11-09 |